These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10440813)

  • 1. Point mutations in the varicella-zoster virus DNA polymerase gene confers resistance to foscarnet and slow growth phenotype.
    Visse B; Huraux JM; Fillet AM
    J Med Virol; 1999 Sep; 59(1):84-90. PubMed ID: 10440813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different mutations in the HHV-6 DNA polymerase gene accounting for resistance to foscarnet.
    Bonnafous P; Naesens L; Petrella S; Gautheret-Dejean A; Boutolleau D; Sougakoff W; Agut H
    Antivir Ther; 2007; 12(6):877-88. PubMed ID: 17926642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
    Andrei G; De Clercq E; Snoeck R
    Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single amino acid change in DNA polymerase is associated with foscarnet resistance in a varicella-zoster virus strain recovered from a patient with AIDS.
    Visse B; Dumont B; Huraux JM; Fillet AM
    J Infect Dis; 1998 Nov; 178 Suppl 1():S55-7. PubMed ID: 9852975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance testing of clinical varicella-zoster virus strains.
    Sauerbrei A; Taut J; Zell R; Wutzler P
    Antiviral Res; 2011 Jun; 90(3):242-7. PubMed ID: 21539861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
    Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
    J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS.
    Baldanti F; Underwood MR; Stanat SC; Biron KK; Chou S; Sarasini A; Silini E; Gerna G
    J Virol; 1996 Mar; 70(3):1390-5. PubMed ID: 8627655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
    Schmit I; Boivin G
    J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic and genetic characterization of varicella-zoster virus mutants resistant to acyclovir, brivudine and/or foscarnet.
    Bleymehl K; Cinatl J; Schmidt-Chanasit J
    Med Microbiol Immunol; 2011 Aug; 200(3):193-202. PubMed ID: 21373931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotypic characterization of the DNA polymerase and sensitivity to antiviral compounds of foscarnet-resistant herpes simplex virus type 1 (HSV-1) derived from a foscarnet-sensitive HSV-1 strain.
    Saijo M; Suzutani T; Morikawa S; Kurane I
    Antimicrob Agents Chemother; 2005 Feb; 49(2):606-11. PubMed ID: 15673740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation in the UL54 gene of human cytomegalovirus isolates that confers resistance to foscarnet.
    Ducancelle A; Champier G; Alain S; Petit F; Le Pors MJ; Mazeron MC
    Antivir Ther; 2006; 11(4):537-40. PubMed ID: 16856628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus.
    Quinlivan M; Gershon AA; Steinberg SP; Breuer J
    J Med Virol; 2005 Jan; 75(1):174-80. PubMed ID: 15543576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory activity of oxyresveratrol on wild-type and drug-resistant varicella-zoster virus replication in vitro.
    Sasivimolphan P; Lipipun V; Likhitwitayawuid K; Takemoto M; Pramyothin P; Hattori M; Shiraki K
    Antiviral Res; 2009 Oct; 84(1):95-7. PubMed ID: 19635502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs.
    Andrei G; Topalis D; Fiten P; McGuigan C; Balzarini J; Opdenakker G; Snoeck R
    J Virol; 2012 Mar; 86(5):2641-52. PubMed ID: 22190713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus].
    Morfin F; Frobert E; Thouvenot D
    Ann Biol Clin (Paris); 2003; 61(1):33-40. PubMed ID: 12604384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain.
    Sauerbrei A; Eichhorn U; Gawellek S; Egerer R; Schacke M; Wutzler P
    J Med Virol; 2003 Oct; 71(2):313-9. PubMed ID: 12938208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases.
    Schnute ME; Cudahy MM; Brideau RJ; Homa FL; Hopkins TA; Knechtel ML; Oien NL; Pitts TW; Poorman RA; Wathen MW; Wieber JL
    J Med Chem; 2005 Sep; 48(18):5794-804. PubMed ID: 16134946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term foscarnet therapy remodels thymidine analogue mutations and alters resistance to zidovudine and lamivudine in HIV-1.
    Mathiesen S; Dam E; Roge B; Joergensen LB; Laursen AL; Gerstoft J; Clavel F
    Antivir Ther; 2007; 12(3):335-43. PubMed ID: 17591023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential switching of DNA polymerase and thymidine kinase-mediated HSV-1 drug resistance in an immunocompromised child.
    Stránská R; van Loon AM; Bredius RG; Polman M; Nienhuis E; Beersma MF; Lankester AC; Schuurman R
    Antivir Ther; 2004 Feb; 9(1):97-104. PubMed ID: 15040541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A novel colorimetric test to study the susceptibility of human cytomegalovirus DNA polymerase to foscarnet].
    Ducancelle A; Alain S; Scieux C; Fillet AM; Petit F; Sanson-Le Pors MJ; Mazeron MC
    Pathol Biol (Paris); 2005; 53(8-9):551-5. PubMed ID: 16084026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.